// App-Quantinova.ai

AB1338-HPR : GLOBAL PATIENT PERSPECTIVE ON TOP CHALLENGES IN LUPUS CARE AND RESEARCH PARTICIPATION

Researchers

Presenter

  • K. Tse

Principal Investigators

  • K. Arntsen

  • S. C. Bae

  • L. Bloch

  • I. N. Bruce

  • K. Costenbader

  • B. Dickerson

  • T. Drner

  • K. Getz

  • A. Kao

  • S. Manzi

  • E. F. Morand

  • S. Raymond

  • B. H. Rovin

  • L. Schanberg

  • V. Werth

  • J. Von Feldt

  • D. Zook

  • L. Hanrahan

Medical Centers

  • The Lupus Foundation of America, Washington, D.C., United States of America

  • Tufts Center for the Study of Drug Development, Boston, United States of America

  • Lupus and Allied Diseases Association, Verona, United States of America

  • Hanyang University Hospital for Rheumatic Diseases, Department of Rheumatology, Seoul, Korea, Republic of (South Korea)

  • Faegre Drinker, Washington, DC, United States of America

  • School of Biological Sciences The University of Manchester, Division of Musculoskeletal and Dermatological Sciences, Manchester, United Kingdom

  • Brigham and Women’s Hospital, Rheumatology, Inflammation, and Immunity, Boston, United States of America

  • Aurinia Pharmaceuticals Inc., Victoria, BC, Canada

  • Charite University Hospital, Berlin, Germany.

  • EMD Serono Research and Development Institute, Inc. (a business of Merck KGaA, Darmstadt, Germany), Billerica, MA

  • Autoimmunity Institute, Allegheny Health Network, Pittsburgh, United States of America

  • Monash University, Medicine, School of Clinical Sciences at Monash Health, Melbourne, Australia

  • Ohio State University Wexner Medical Center, United States

  • Duke University Medical Center - Durham - United States of America

  • Perelman School of Medicine at the University of Pennsylvania and CMCVAMC, Department of Dermatology, Philadelphia, United States of America

  • Perelman School of Medicine, Philadelphia, United States of America

Locations

  • United States

  • United Kingdom

  • Canada

  • Germany

  • Australia

Companies

  • N/A

Study Components

Therapeutic Area

  • Autoimmune (AI)

Disease

  • Lupus

Biomarkers

  • N/A

Drug/Treatment

  • N/A

Outcome

  • N/A

Study Design

  • N/A

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • Genzyme and Sanofi

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved